Integrating harm reduction and clinical care: Lessons from Covid-19 respite and recuperation facilities.
J Subst Abuse Treat
; 118: 108103, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-709576
ABSTRACT
In response to the novel coronavirus 2019 (Covid-19) pandemic, many people experiencing homelessness and substance use disorders entered respite and recuperation facilities for care and to isolate and prevent subsequent SARS-CoV-2 transmission. However, because drug use was officially prohibited in these facilities, we observed people who use substances leaving isolation temporarily or prematurely. The initial Covid-19 surge magnified the need for harm reduction access for those who use substances to ensure their safety and well-being and that of their local communities. In this commentary, we argue that expanding harm reduction access is crucial for subsequent waves of SARS-CoV-2 infection and also for patients who use substances and are hospitalized for other reasons.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Ill-Housed Persons
/
Coronavirus Infections
/
Substance-Related Disorders
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
J Subst Abuse Treat
Journal subject:
Substance-Related Disorders
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS